chr17-15708212-A-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001130842.2(ZNF286A):​c.299A>G​(p.Lys100Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000347 in 1,441,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K100T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000035 ( 0 hom. )

Consequence

ZNF286A
NM_001130842.2 missense

Scores

1
18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.416

Publications

0 publications found
Variant links:
Genes affected
ZNF286A (HGNC:13501): (zinc finger protein 286A) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be integral component of membrane. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
ZNF286A-TBC1D26 (HGNC:55384): (ZNF286A-TBC1D26 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring ZNF286A and TBC1D26 genes. This transcript is thought to be non-coding because it would be subject to nonsense-mediated mRNA decay (NMD). [provided by RefSeq, Nov 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04533416).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF286ANM_001130842.2 linkc.299A>G p.Lys100Arg missense_variant Exon 5 of 6 ENST00000583566.6 NP_001124314.1 Q9HBT8-1B2RCD9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF286AENST00000583566.6 linkc.299A>G p.Lys100Arg missense_variant Exon 5 of 6 1 NM_001130842.2 ENSP00000464063.1 Q9HBT8-1
ZNF286A-TBC1D26ENST00000413242.6 linkn.299A>G non_coding_transcript_exon_variant Exon 5 of 17 2 ENSP00000458062.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000347
AC:
5
AN:
1441518
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
717534
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32672
American (AMR)
AF:
0.00
AC:
0
AN:
42092
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25494
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38422
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5676
European-Non Finnish (NFE)
AF:
0.00000454
AC:
5
AN:
1102174
Other (OTH)
AF:
0.00
AC:
0
AN:
59146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0010
T;.;T;T;.;.;.;T;T;T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.010
T;T;.;T;.;T;T;.;T;T
M_CAP
Benign
0.0022
T
MetaRNN
Benign
0.045
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-0.89
N;.;N;.;.;.;.;N;.;.
PhyloP100
0.42
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.21
N;.;.;.;N;.;.;.;N;.
REVEL
Benign
0.054
Sift
Benign
0.071
T;.;.;.;T;.;.;.;T;.
Sift4G
Benign
0.32
T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
B;.;B;.;.;.;.;B;.;.
Vest4
0.059
MutPred
0.22
Loss of ubiquitination at K100 (P = 0.0244);.;Loss of ubiquitination at K100 (P = 0.0244);.;Loss of ubiquitination at K100 (P = 0.0244);.;Loss of ubiquitination at K100 (P = 0.0244);Loss of ubiquitination at K100 (P = 0.0244);Loss of ubiquitination at K100 (P = 0.0244);.;
MVP
0.29
MPC
0.054
ClinPred
0.096
T
GERP RS
1.3
Varity_R
0.022
gMVP
0.083
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1467218222; hg19: chr17-15611526; API